These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 316092)

  • 1. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Holland DR; Yen TT; Bemis KG; Stamm NB
    Life Sci; 1979 Oct; 25(14):1237-42. PubMed ID: 316092
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Owen JE
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):137-40. PubMed ID: 6975958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of 3,4-dihydroxyphenylacetic acid concentration by L-5-hydroxytryptophan in control and fluoxetine-pretreated rats.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1981 Jun; 33(6):406-7. PubMed ID: 6115023
    [No Abstract]   [Full Text] [Related]  

  • 4. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in the elevated blood pressure of Dahl salt-sensitive rats treated chronically with L-5-hydroxytryptophan.
    Baron A; Riesselmann A; Fregly MJ
    Pharmacology; 1991; 42(1):15-22. PubMed ID: 1829234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding.
    Goudie AJ; Thornton EW; Wheeler TJ
    J Pharm Pharmacol; 1976 Apr; 28(4):318-20. PubMed ID: 6727
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake.
    Slater IH; Jones GT; Moore RA
    Neuropharmacology; 1978 Jun; 17(6):383-9. PubMed ID: 209365
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chronic fluoxetine administration on serotonin metabolism.
    Hwang EC; Magnussen I; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):79-98. PubMed ID: 6157184
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of brain serotonin alterations on hypothermia produced by chlorpromazine in rats.
    Lin MT; Chern YF; Chow CF; Li YP
    Pharmacology; 1979; 18(3):128-35. PubMed ID: 156373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of plasma corticosterone by swim stress and insulin-induced hypoglycemia in control and fluoxetine-pretreated rats.
    Fuller RW; Snoddy HD
    Endocr Res Commun; 1977; 4(1):11-23. PubMed ID: 301086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol.
    Lemberger L; Rowe H; Bergstrom RF; Farid KZ; Enas GG
    Clin Pharmacol Ther; 1985 Jun; 37(6):658-64. PubMed ID: 3874037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pehidine interaction with clorgyline, pargyline, or 5-hydroxytryptophan: lack of enhanced pethidine lethality or hyperpyrexia in mice.
    Leander JD; Batten J; Hargis GW
    J Pharm Pharmacol; 1978 Jun; 30(6):396-8. PubMed ID: 26781
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D; Langwinski R
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake.
    Fuller RW; Snoddy HD; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):193-6. PubMed ID: 1079087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlordiazepoxide-fluoxetine interactions on food intake in free-feeding rats.
    Feldman RS; Smith WC
    Pharmacol Biochem Behav; 1978 Jun; 8(6):749-52. PubMed ID: 308664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inability of chronic fluoxetine to potentiate a serotonin mediated effect.
    Sugrue MF
    Commun Psychopharmacol; 1980; 4(2):131-4. PubMed ID: 6968660
    [No Abstract]   [Full Text] [Related]  

  • 18. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
    Ishii H; Itoh K; Nose T
    Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to man.
    Bowsher DJ; Rowe H; Farid NA; Tenbarge JB; Lemberger L
    Life Sci; 1988; 42(25):2569-75. PubMed ID: 3260321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine, pharmacology and physiologic disposition.
    Lemberger L; Farid NA; Bergstrom RF; Wolen RL
    Int J Obes; 1987; 11 Suppl 3():157-61. PubMed ID: 3501991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.